Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | genetic association 0.07 (overall 0.04) | 0.07 |
| cell type Human Protein Atlas | cell type enhanced, including other brain neurons; strongest in late spermatids | 0.75 |
| chemistry Open Targets | reachable by antibody | 0.45 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | no papers tie it to Parkinson's yet | 1.00 |
| pathways Reactome | 1 pathway; mostly other | 0.30 |
No case: the score is under the bar. Receipt 5753
Sealed predictions
- PODXL2 in dopamine neurons, braak-0.37 (p 0.334) → +0.17 (p 0.656)receipt 5761
Swarm cases
receipt 5761: PODXL2 in dopamine neurons, braak
- power
- full sample -0.14 (p 0.573, n 18), 95% CI -0.57 to +0.35. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.14 (p 0.573, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.37 (p 0.135, n 18). could be the mix.
- skeptic
- leave-one-out range -0.23 to -0.03, sign flips 0; without severely affected donors -0.14 (p 0.573, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for PODXL2 in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts